Katsube Sota, Matsumoto Satohiro, Misawa Masahiro, Kakizawa Nao, Hashimoto Ryo, Mizutani Taku, Matsumoto Keita, Yoshikawa Shuhei, Mashima Hirosato
Department of Gastroenterology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Department of Obstetrics and Gynecology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Biologics. 2024 May 6;18:107-113. doi: 10.2147/BTT.S457300. eCollection 2024.
The patient was a 50-year-old Japanese woman who was diagnosed with total-colitis-type ulcerative colitis (UC) at the age of 26 years. She was treated with mesalazine and azathioprine, and her disease activity was well controlled. At the age of 50 years, the patient was experiencing fever, abdominal pain, diarrhea, bloody stool, and anal pain, which led to a diagnosis of a relapse of UC. Although steroid therapy was administered and tended to improve her symptoms, fecaloid vaginal discharge occurred, and rectovaginal fistula (RVF) was confirmed. Colostomy was performed, and infliximab was initiated as maintenance therapy for UC. All symptoms improved, and RVF closure was confirmed 6 months after the initiation of infliximab. To date, she has been free from relapse of UC. There have been only a few reports of UC complicated by RVF, and this condition is often difficult to treat. To the best of our knowledge, no other case of UC complicated by RVF in which the fistula was closed after treatment with colostomy and infliximab has been previously reported; thus, our report of the present case is valuable to the literature.
该患者为一名50岁的日本女性,26岁时被诊断为全结肠炎型溃疡性结肠炎(UC)。她接受了美沙拉嗪和硫唑嘌呤治疗,疾病活动得到良好控制。50岁时,患者出现发热、腹痛、腹泻、便血和肛门疼痛,导致UC复发的诊断。尽管给予了类固醇治疗且症状有改善趋势,但出现了粪样阴道分泌物,直肠阴道瘘(RVF)得到确诊。进行了结肠造口术,并开始使用英夫利昔单抗作为UC的维持治疗。所有症状均有改善,英夫利昔单抗治疗开始6个月后确认RVF闭合。迄今为止,她未出现UC复发。仅有少数关于UC合并RVF的报道,且这种情况通常难以治疗。据我们所知,此前尚无其他UC合并RVF的病例在结肠造口术和英夫利昔单抗治疗后瘘管闭合的报道;因此,我们对本病例的报告对文献具有重要价值。